Thomas Günther

8PUBLICATIONS
8CO-AUTHORS
Molecular targetsBiomolecular modelling and designReaction engineering (excl. nuclear reactions)GlycoconjugatesFood engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 10, 2026
Evaluation of treatment efficacy of the 161Tb- and 177Lu-Labeled GRPR antagonists AMTG and RM2 in a mouse model of prostate cancer.

|Sep 01, 2025
Studies on the impact of modifications at the Gln-Trp site in RM2-based GRPR ligands.

Sebastian Fischer, Lena Koller, Sandra Dominelli

|Mar 01, 2024
Significant reduction of activity retention in the kidneys via optimized linker sequences in radiohybrid-based minigastrin analogs.

Nadine Holzleitner, Sebastian Fischer, Isabel Maniyankerikalam

|Aug 09, 2023
Synthesis of 177Lu-Labeled, Somatostatin-2 Receptor-Targeted Metalla-Assemblies: Challenges in the Design of Supramolecular Radiotherapeutics.

Sandra Deiser, Marike Drexler, Guillermo Moreno-Alcántar

|Jul 08, 2023
Investigation of the structure-activity relationship at the N-terminal part of minigastrin analogs.

Nadine Holzleitner, Thomas Günther, Amira Daoud-Gadieh

|Mar 29, 2023
Development of the First 18F-Labeled Radiohybrid-Based Minigastrin Derivative with High Target Affinity and Tumor Accumulation by Substitution of the Chelating Moiety.

Thomas Günther, Nadine Holzleitner, Daniel Di Carlo

Pageof 2

Frequent Collaborators

2 joint publications

Angela Casini

2 joint publications

Nadine Holzleitner

2 joint publications

Constantin Lapa

1 joint publications

León Stopper